학술논문
29P Characterization of T cell responses induced by the individualized mRNA neoantigen vaccine autogene cevumeran in adjuvant stage II (high risk)/stage III colorectal cancer (CRC) patients (pts) from the biomarker cohort of the phase II BNT122-01 trial.
Document Type
Article
Author
Source
Subject
*T cells
*COLORECTAL cancer
*BIOMARKERS
*MESSENGER RNA
*VACCINES
*
*
*
*
Language
ISSN
0923-7534